Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Journal of International Obstetrics and Gynecology    2016, 43 (3): 249-249.  
    Abstract2601)      PDF (347KB)(24671)      
    Related Articles | Metrics
    Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Status and Controversy
    SUN Fu-qing, SHEN Ming-hong, WANG Sha, DUAN Hua
    Journal of International Obstetrics and Gynecology    2021, 48 (1): 35-40.   DOI: 10.12280/gjfckx.20200665
    Abstract5193)   HTML58)    PDF (735KB)(10306)      

    Uterine smooth muscle tumor of uncertain malignant potential (STUMP) is the neoplasm with pathological features that preclude an equivocal diagnosis of leiomyosarcoma, but that do not fulfill the criteria for leiomyoma or its variants, and raise concerns that the tumor may behave in a malignant fashion. The incidence of STUMP is relatively low. The clinical features and imaging manifestations of STUMP are lack of specificity. In most cases, STUMP grow slowly, and the prognosis is worth expecting. However, the actual course of this disease is difficult to predict, and there is a risk of recurrence and malignant transformation. The diagnosis of STUMP depends solely on histopathological examination, but no consensus has been reached on pathological diagnostic criteria. Immunohistochemical molecular typing and genomic analysis may be helpful for the assessment of prognosis factors, but the evidence is limited and further researches are needed. Although there are no guidelines or consensus governing the treatment of STUMP, total hysterectomy with or without bilateral salpingo-oophorectomy is the standard treatment if fertility is completed, whereas myomectomy alone can be taken into consideration in young patients who desire to preserve childbearing potential. Regular follow-up after surgery is important to detect missed diagnosis and tumor recurrence in time.

    Reference | Related Articles | Metrics
    Research Progress of Endometrial Cancer Classification
    JIN Ming-zhu, DI Wen
    Journal of International Obstetrics and Gynecology    2020, 47 (1): 15-18.  
    Abstract2526)      PDF (734KB)(10299)      
    Endometrial carcinoma is one of the three major malignant tumors in gynecology. The standard treatment is surgery with/without radiotherapy and chemotherapy; for those who desire to retain their fertility can be treated conservatively after consultation and accomplish the operation after childbirth. In 1983, Bockman proposed clinical classification of endometrial cancer, which was divided into typeⅠ(estrogen-dependent) and typeⅡ(non-estrogen-dependent); in 1994, Poulsen classified endometrial cancer into adenocarcinoma, serous adenocarcinoma, mucinous adenocarcinoma, clear cell carcinoma, squamous cell carcinoma, mixed carcinoma, and undifferentiated carcinoma by histopathology; in 2013, endometrial carcinoma was divided into four types based on different mutation patterns and copy number by the Cancer Genome Atlas (TCGA): polymerase epsilon(POLE) mutated, microsatellite instability, copy number-low and copy number-high. The molecular classification has important guiding significance for the precise treatment of patients with different subtypes and prognosis prediction of patients. In this review, we summarize three classifications of endometrial carcinoma, list their advantages and limitations, and highlight the clinical significance of endometrial cancer. The continuous improvement of classification of endometrial cancer will help to understand the heterogeneity in prognosis, guide the choice of treatment strategies, and lay a theoretical foundation for standardized, individualized and humanized treatment in the era of precision medicine.
    Reference | Related Articles | Metrics
    The Role of Androgens in the Pathogenesis and Treatment of Female Reproductive Endocrine Diseases
    XU Xiao,LI Xue-lian
    Journal of International Obstetrics and Gynecology    2019, 46 (1): 5-10.  
    Abstract2102)      PDF (827KB)(10260)      
    Androgens play a vital role in maintaining the health of the female reproductive system. Either excessive or deficient androgens may result in the occurrence of female reproductive endocrine diseases. Hyperandrogenism is one of the important characteristics and pathogenic factors of polycystic ovary syndrome (PCOS). Hyperandrogenism may play its pathogenic role in women with PCOS by influencing epigenetic modification, hypothalamic neuroendocrine, follicular development, ovarian function and metabolism. The mechanism of androgens action in recurrent spontaneous abortion mainly affects endometrial receptivity and embryo implantation. Women with premature ovarian insufficiency often have low testosterone levels. Androgen deficiency may be associated with granulosa cells apoptosis and diminished ovarian reserve. The treatment of androgen reduction is an important part of the clinical treatment of PCOS, while androgen supplements can be used in women with low function ovarian reserve, whereas further studies are needed due to the lack of long-term safety and efficacy.
    Related Articles | Metrics
    Anatomic Research Progress of Transvaginal Hysterectomy
    GUO Zhuo-dan,WANG Wen-zhen,HAO Qian,WU Su-hui,LIU Xiao-chun
    Journal of International Obstetrics and Gynecology    2018, 45 (4): 435-438.  
    Abstract1949)      PDF (720KB)(10150)      
    Transvaginal hysterectomy (TVH) has the advantages of small trauma, little bleeding, no scar on the abdomen, quicker recovery, shorter hospitalization time, fewer complications and lower costs. "Under the same conditions, transvaginal route should be the first option for hysterectomy" is a consensus reached by gynecological experts all over the world. Although there is solid evidence to support vaginal access, abdominal total hysterectomy still accounts for a large proportion of domestic and foreign hospitals. The main reasons for the widespread development of TVH are the experience of the surgeon and the level of the vaginal operation. The biggest obstacle is the unfamiliarity of the anatomical plane. The concern of bleeding and urinary bladder damage, combined with the operation of TVH vision and high technical requirements of operation, hindered the development of vaginal surgery. Therefore, this article reviews the anatomical knowledge involved in TVH, which aims to provide the application of anatomical basis for transvaginal operation, and to provide useful data for better vaginal surgery.
    Related Articles | Metrics
    The Formation of Chromosome Mosaicism and Its Influence for Prenatal Screening and Diagnosis
    GUO Ying, CHANG Ying, CHEN Xu
    Journal of International Obstetrics and Gynecology    2018, 45 (1): 14-18.  
    Abstract3011)      PDF (774KB)(9992)      
    With the advent of cell-molecular biology, prenatal screening and diagnostic methods have also changed, and more data need to be interpreted correctly,which is a challenge for prenatal diagnosis doctors. Among them, chromosome mosaicism is one of the most important factors that affect the accuracy of prenatal screening and diagnosis. Chromosome mosaicism is prevalence in human and affected by many factors, such as mother, father, placental and other factors. The main reason for the formation of mosaicism is  chromosomal error separation in mitotic. The clinical manifestations of mosaicism are affected by a variety of factors, and their clinical outcomes are unique to each individual. The effect of mosaicism on prenatal screening and diagnosis are mainly in two aspects: ①Screening of cell-free fetal DNA (cfDNA) in maternal blood. Although a large number of related literature reported its higher detection rate for 21,18,13 trisomy, while cfDNA from the placenta, and confined placental mosaicism is an important factor affecting the accuracy of the results. ②If the chronic karatype is mosaicism,amniocentesis is required for futher confirmation. In conclusion, understanding the origin, mechanism and clinical outcome of chromosome mosaicism correctly, can provide patients with more valuable genetic information, and it′s importance for providing genetic counseling in prenatal screening and diagnosis.
    Related Articles | Metrics
    Current status of diagnosis and treatment of borderline ovarian tumors
    Journal of International Obstetrics and Gynecology    2017, 44 (1): 18-22.  
    Abstract2100)      PDF (719KB)(9933)      
    Abstract:Borderline ovarian tumors (BOT) is a low malignant potential ovarian tumors,it has the characteristics of early onset, early detection and good prgnosis, but the preoperative diagnosis is difficult. Although the serum tumor markers, pelvic ultrasound and intraoperative frozen biopsy could assist the diagnosis, but the accuracy is low. In recent years, the surgical treatment of BOT gradually changed from radical operation to fertility preserving surgery. However, there has been widespread controversy about its early diagnosis, therapy and prognosis, this article reviews the research status of BOT diagnosis and treatment, in order to provide references for the clinical diagnosis and treatment of BOT and new treatment technology research.
    Related Articles | Metrics
    Research Progress of Stem Cell Repair Following Endometrial Injury
    HAN Xiao,HUANG Xiao-wu
    Journal of International Obstetrics and Gynecology    2019, 46 (4): 365-369.  
    Abstract2160)      PDF (879KB)(9831)      
    Endometrial repair is a common pathophysiological process in obstetrics and gynecology. It is divided into physiological endometrial repair and endometrial repair following injury. Physiological repair is the process of self-exfoliation and regeneration of the intima. It does not form scars, unlike the intimal repair, which is often incomplete. When there is an injury to the basal layer of the endometrium or destruction of the endometrial growth microenvironment,it will result in endometrial proliferation dysfunction, endometrial regeneration disorders, and even scar formation and intrauterine adhesion. These changes will affect the potential for implantation of embryos, leading to female infertility or repeated miscarriage. At present, how to promote the repair of endometrial injury still poses a great challenge. In recent years, stem cell research on endometrial repair has attracted much attention. This paper aims to review the pathophysiology of endometrial regeneration and the research progress of stem cell repair following endometrial injury.
    Related Articles | Metrics
    Progress in Research on Uterine Sarcoma
    TAO Sheng-nan,ZHOU Ying,SUN Jin,YE Gui-ping,HU Lai-hua,HU Wei-ping
    Journal of International Obstetrics and Gynecology    2019, 46 (3): 249-252.  
    Abstract1941)      PDF (716KB)(9813)      
    Uterine sarcoma is a malignant tumor that occurs in the female genital system. Its incidence is low and its prognosis is poor. Its manifestations mainly include abnormal vaginal bleeding, abdominal pain and abdominal mass. Serological indicators such as serum lactate dehydrogenase, serum neutrophil to lymphocyte ratio (NLR), and ultrasound and magnetic resonance examinations can assist in the preoperative diagnosis of uterine sarcoma, but the diagnosis still depends on postoperative pathology. Uterine sarcomas include three pathological types: uterine leiomyosarcoma, endometrial stromal sarcoma and uterine adenosarcoma. Whole uterus and double attachment resection are standard surgical methods, and adjuvant treatment can be selected according to different pathological types and surgical stages. This article summarizes the clinical manifestations, auxiliary examinations, pathological features, treatment and prognosis of uterine sarcoma by consulting domestic and foreign literature.
    Related Articles | Metrics
    Therapy for Elderly Patients With Ovarian Cancer.
    Journal of International Obstetrics and Gynecology    2017, 44 (1): 13-17.  
    Abstract2163)      PDF (737KB)(9801)      
    Epithelial ovarian cancer is a cancer of older women. Close to half (45%) of women diagnosed with ovarian cancer will be older than age 64. This ratio is expected to increase in the coming decades as our population ages and life-expectancy improves, while Older women with ovarian cancer receive less surgery and chemotherapy, suffer worse toxicity from surgery and chemotherapy,and have worse survival. The majority of elderly patients are able to tolerate the standard of care for ovarian cancer including initial surgical cytoreduction followed by platinum and taxane chemotherapy. To offer optimal radical management,Pretreatment assessment is needed. Large prospective clinical trials involving elderly ovarian cancer patients are warranted to offer justified evidenced based optimal treatment for those who will be benefited from the treatment.
    Related Articles | Metrics
    Journal of International Obstetrics and Gynecology    2017, 44 (1): 52-55.  
    Abstract2561)      PDF (768KB)(9798)      
    Related Articles | Metrics
    Research Progress of Copy Number Variation Sequencing in Prenatal Diagnosis
    LI Feng-jin, YAO Xin-yu, ZHANG Yu-ping
    Journal of International Obstetrics and Gynecology    2021, 48 (1): 75-78.   DOI: 10.12280/gjfckx.20200527
    Abstract2559)   HTML72)    PDF (711KB)(9762)      

    It′s reported that congenital heart disease, polydactyly (toe), cleft lip, congenital hydrocephalus and clubfoot rank among the top five in birth defects. Chromosomal microdeletions and microduplications are related to these diseases. Prenatal diagnosis is the main mean to prevent birth defects, which is to use advanced technology to diagnose fetal congenital diseases before birth. Research has shown that copy number variation sequencing (CNV-seq) can diagnose prenatal chromosomal microdeletions and microduplications. It increased the detection rate of chromosomal abnormalities to 2.8%. CNV-seq is a whole genome sequencing technology developed based on high-throughput sequencing. It has a wide range of detection and high resolution, it covers genome-wide microdeletion and microduplication abnormalities. It has been gradually applied to the detection of fetal congenital diseases and abortion tissues. It can also be used to identify chromosomal abnormalities of unknown origin. The paper reviews the research progress of CNV-seq in prenatal diagnosis.

    Reference | Related Articles | Metrics
    Journal of International Obstetrics and Gynecology    2018, 45 (3): 355-357.  
    Abstract1685)      PDF (2824KB)(9739)      
    Related Articles | Metrics
    Gene Therapy Advances of CRISPR/Cas9 in β-thalassaemia
    LI Huan-rong,LI Zeng-yan
    Journal of International Obstetrics and Gynecology    2017, 44 (2): 185-188.  
    Abstract2392)      PDF (715KB)(9590)      
    【Abstract】  β-thalassaemia is a genetic disease of human β-globin (HBB) gene mutation, there is no cure possible, leading to the disorder of globin expression. CRISPR/Cas system, as the acquired immune system of bacteria and archaea, can transform the genome of many organisms at present. CRISPR/Cas9 systems is widely used for the advantages of easy programming, inexpensive construction, high specificity and multiplexed genome editing. The latest study using CRISPR/Cas9 systems combined with induced pluripotent stem cells to correct human HBB has become possible,meanwhile produces normal hemoglobin to reduce the symptom of patients with β-thalassaemia. The outcome will be a tremendous disasters, if off-target effect occured in human, that′s scientist worried about. To increase the safety of CRISPR/Cas9 gene editing, the latest research avoid the off-targets effect by increasing the specificity of CRISPR resection and controlling the Cas9 effectively. We reviewed the latest researches on the CRISPR/Cas9 systems and deal with off target effects.
    【Keywords】 
    Related Articles | Metrics
    Clear Cell Adenocarcinoma of Cervical:Clinical Analysis of 13 Cases
    HU Rui,HOU Wen-jing,ZHANG Meng-zhen
    Journal of International Obstetrics and Gynecology    2019, 46 (2): 146-149.  
    Abstract1933)      PDF (749KB)(9518)      
    Objective:To discuss the clinical and pathological characteristics, therapy and prognosis of clear cell adenocarcinoma of cervical(CCAC). Methods: We performed a retrospective review of 13 patients with CCAC who were diagnosed and treated at the First Affiliated Hospital of Zhengzhou University from April 2013 to December 2017. Result: The age of the patients was (53.6±13.9) years,of which 9 (69.2%) were older than 40 years and 4 (30.8%) were younger than 40 years, 2 were adolescents. The International Federation of Gynecology and Obstetrics stage: 46.15% (n=6) stage I, 46.15% (n=6) stage II, 7.7% (n=1) stage III. Twelve patients underwent surgery followed by radiotherapy and chemotherapy, including 3 patients treated by neoadjuvant chemotherapy, 9 postoperative adjuvant radiotherapy and/or chemotherapy. One patient was treated by radiotherapy alone. The median follow-up time was 24 months (6-60 months). 4 patients died and 2 patients had multiple metastases. The 1-year, 2-year and 5-year survival rates were 12/13、11/13 and 9/13, respectively. Conclusions: CCAC has low incidence, nonspecific clinical manifestations and poor prognosis with lymph node metastasis. The individualized comprehensive treatment of surgery followed by radiotherapy and chemotherapy can significantly improve the patient′s condition.
    Related Articles | Metrics
    Research Progress in Robotic-Assisted Sacrocolpopexy
    LIU Chang,YANG Pan-pan,ZHANG Jia-jun,LIU Cui-ping,QING Li-mei,WANG Xiao-hui
    Journal of International Obstetrics and Gynecology    2019, 46 (4): 374-377.  
    Abstract1816)      PDF (2030KB)(9505)      
    Pelvic organ prolapse (POP) has become a common condition in adult women as risk factors such as age, obesity and childbirth increase. The treatment and management of POP are obviously individualized and diversed, and the optimal strategy should be selected from a variety of strategies according to the individual situation of patients. The surgical strategy also developed from the initial open surgery to minimally invasive laparoscopic technology, and now the minimally invasive robotic technology. Robotic-assisted sacrocolpopexy (RASC) is an emerging surgical technique. Recent studies have shown that RASC not only has the advantages of less blood loss, faster internal recovery, and less risk of mesh exposure, but its short-term and medium-term postoperative repair effect is similar to that of abdominal sacrocolpopexy(ASC). Although RASC has a long learning curve, unclear long-term efficacy and high cost, these problems will be gradually overcome by the development of this technology.
    Related Articles | Metrics
    Advances in Research on Signaling Pathway Related to Endometriosis
    ZHU Xiao-lin,HAN Ya-guang,HAN Yan-hua,XU Feng-hua,CONG Jing,WANG Xue-lian
    Journal of International Obstetrics and Gynecology    2019, 46 (4): 370-373.  
    Abstract1934)      PDF (771KB)(9501)      
    Endometriosis (EMs), as a difficult disease recognized by gynecologists, has seriously affected the physical and mental health of women. Because of its polymorphism, invasion and extensiveness, there is no uniform conclusion on the pathogenesis of EMs. Abnormal activation of related signaling pathways and the interaction of multiple cytokines can lead to the formation of ectopic endometrium adhesion, invasion and inflammation. At present,mitogen-activated protein kinases (MAPKs) pathway, Wnt/β-catenin pathway, transforming growth factor β (TGF-β)/Smad pathway, nuclear factor κB (NF-κB) pathway, Ras homolog gene/ Rho-associated coiled coil-forming protein kinase (Rho/ROCK) pathway, Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway are closely related to the pathogenesis of EMs. This review aims to illustrate the pathogenesis of EMs by explaining these mentioned pathways,to provide a new strategy for finding effective drugs to treat EMs.
    Related Articles | Metrics
    Advance in Screening Methods of Endometrial Cancer
    SUN Jin,HU Wei-ping
    Journal of International Obstetrics and Gynecology    2017, 44 (2): 155-158.  
    Abstract2058)      PDF (663KB)(9492)      
     Endometrial cancer (EC) is the most common malignant tumor in female genital system, now the morbidity of EC is increasing gradually with a trend of attacking young adults, so the screening of precancerous lesion is increasingly important. It means we should take some examination in common people, pay attention to the lesion, and recognize the disease in time, now clinical diagnosis methods include serological examination, TVS, endometrial cytology test(ECT), pathological diagnosis and immunohistochemical, however these inspections have their virtues and disadvantages, it′s impractical to choose one of them as a reliable way applying to general population, so it needs a lot of exploration to find a available method and put into use. When it′s necessary, we should combine some examinations to help diagnosis.
    Related Articles | Metrics
    The Research Progress of Long Non-coding RNA in Endometrial Carcinoma
    LI Yi-bing,MA Xiao-xin
    Journal of International Obstetrics and Gynecology    2017, 44 (2): 150-154.  
    Abstract1997)      PDF (744KB)(9434)      
      Long non-coding RNA (lncRNA) plays an extremely important role of regulation in many pathophysiological processes of organism, whose dysfunction is much related to the development and progression of tumors. It has become a research hotspot of many disease mechanisms recently due to its large number, variety and polytropic function. Endometrial carcinoma is one of the most common malignant tumors in female reproductive system, which has much relation with lncRNA. The research of lncRNA in endometrial carcinoma is becoming more and more. With the progressing of techniques and methods of the research, it will help reveal the development and progression of endometrial carcinoma to explore the regulation mechanism of lncRNA to endometrial carcinoma. It can also provide a new pathway to the primary diagnosis and treatment of this disease, and is likely to become a novel marker related to prognosis or a target of drug treatment. This article will summarize the research progression of lncRNA in endometrial carcinoma.
    Related Articles | Metrics
    Research Progress of Biomarkers Related to Endometriosis
    JIANG Mei, YUE Wen-tao
    Journal of International Obstetrics and Gynecology    2021, 48 (1): 5-9.   DOI: 10.12280/gjfckx.20200561
    Abstract1477)   HTML60)    PDF (710KB)(9299)      

    Endometriosis (EMs) is a common gynecologic disease and characterized as a chronic and hormone-dependent disease in which endometrial glands and interstitial tissue are implanted outside the uterine cavity. Despite decades of research, there are no sufficiently sensitive and specific signs and symptoms nor accepted biomarkers for the clinical definitively diagnosis of EMs, which hampers prompt diagnosis and treatment. To identify more effective non-invasive diagnostic biomarkers may provide a new thought for improving the clinical efficacy of EMs patients. Hormones, cytokines, chemokines, tumor-associated carbohydrate antigens, biomarkers related to epigenetic regulation and circulating endometrial cells involved in the chronic inflammation of EMs have been extensively studied in the pathogenesis of EMs, but currently no one can be a specific biomarker for EMs. It is of great significance to find highly sensitive and specific EMs biomarkers or a group of biomarkers as auxiliary methods for the diagnosis and monitoring of EMs. With the development of molecular biology and bioinformatics methods, screening approach using high-throughput technologies is expected to discover specific molecular markers related to this disease. This article reviews the latest research progress of EMs-related biomarkers.

    Reference | Related Articles | Metrics